BCA
RDY icon

Berman Capital Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Berman Capital Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$10K Sell
780
-605
-44% -$8.06K ﹤0.01% 1193
2021
Q2 		$20K Buy
1,385
+80
+6% +$1.12K ﹤0.01% 915
2021
Q1 		$16K Sell
1,305
-115
-8% -$1.48K ﹤0.01% 871
2020
Q4 		$20K Sell
1,420
-360
-20% -$4.85K ﹤0.01% 675
2020
Q3 		$24K Sell
1,780
-525
-23% -$6.26K 0.01% 534
2020
Q2 		$24K Sell
2,305
-65
-3% -$661 0.01% 495
2020
Q1 		$19K Buy
2,370
+425
+22% +$3.54K 0.01% 509
2019
Q4 		$15K Buy
1,945
+220
+13% +$1.74K ﹤0.01% 619
2019
Q3 		$13K Buy
1,725
+480
+39% +$3.57K ﹤0.01% 644
2019
Q2 		$9K Sell
1,245
-490
-28% -$3.85K ﹤0.01% 779
2019
Q1 		$14K Buy
1,735
+830
+92% +$6.31K ﹤0.01% 557
2018
Q4 		$6K Buy
+905
New +$6.37K ﹤0.01% 643

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Berman Capital Advisors's RDY Position: Q3 2021 in Review

Berman Capital Advisors reduced its Dr. Reddy's Laboratories (RDY) stake by 44% in Q3 2021, selling an estimated $8.06K and leaving 780 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #1193.

Berman Capital Advisors first reported a position in RDY in Q4 2018 and has held it in 12 quarters since. The position peaked at $24K in Q3 2020. 149 funds tracked by Wall St. Rank hold RDY as of Q3 2021.

  • Berman Capital Advisors held 780 shares of Dr. Reddy's Laboratories worth $10K as of Q3 2021.
  • Berman Capital Advisors sold 605 Dr. Reddy's Laboratories shares in Q3 2021, an estimated $8.06K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #1193 holding.
  • Berman Capital Advisors first reported a position in Dr. Reddy's Laboratories in Q4 2018 and has held it in 12 quarters since.
  • Berman Capital Advisors's Dr. Reddy's Laboratories position peaked at $24K in Q3 2020.
  • 149 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.